Page 1331 - Equine Clinical Medicine, Surgery and Reproduction, 2nd Edition
P. 1331

1306                                       CHAPTER 13



  VetBooks.ir  therapeutic plan should be developed and a decision   13.17
             Once wound evaluation has been completed, a

           about primary or secondary closure reached. Surgical
           debridement is essential and should be performed by
           careful resection of necrotic tissue while preserving
           all  vital  structures.  Overdebridement  may  poten-
           tially delay the healing process or invade and damage
           critical structures such as synovial cavities. Tissues
           with questionable viability should be preserved as
           much as possible. Occasionally, a skin flap may be
           maintained for a few days as a ‘biological’ dressing,
           only to be debrided once fibroplasia has started. It is
           important to understand that wound debridement is   Fig. 13.17  Application of medicinal maggots to a
           also a staged procedure that may continue for sev-  chronically infected foot abscess.
           eral days following initial assessment of the wound.
           Any interaction with the wound should be carried   13.18
           out with at least clean, if not sterile, gloved hands,
           because cross-contamination from the veterinarian’s
           hands is possible.
             Debridement can also be accomplished by medic-
           inal maggot therapy. This involves the use of mag-
           gots (larvae of Lucilia sericata) and is a safe, effective
           and controlled method of healing chronic wounds
           by debridement and disinfection. The maggots are
           sterile or disinfected and have a preference to feed on
           non-vitalised tissue, purulent exudate and metabolic
           wastes of a wound. In wounds they produce disin-  Fig. 13.18  Use of the Versajet™ system to debride an
           fection, debridement, stimulation of healing and   extensive laceration of the dorsal pastern and fetlock.
           inhibition and eradication of biofilms. They do not
           penetrate deep tissues because they require aerobic   evacuation of the debris. It has been shown that its
           conditions to survive. Once the wound bed is ready   use improves precision and reduces the number of
           and devoid of initial contamination, but not cleaned   debridements required, and it is particularly useful
           with antiseptics, the maggots are placed directly   for heavily contaminated wounds. The device comes
           into the wound, being careful not to suffocate them   with a control console to regulate the pressure inten-
           by excessive pressure on the dressing used to cover   sity of the jet and a handpiece with an 8 or 14 mm
           them. Apply 5–10 maggots/cm  for 3–4 days, after   cutting window on a 15° or 45° angled surface. Care
                                     2
           which time they become ineffective. If required, an   must be taken not to remove healthy tissue and
           additional ‘dose’ can be placed. Medicinal maggots   avoid the laceration of large structures such as ves-
           are easily obtained and at the present time their main   sels or nerves, which requires a thorough anatomical
           use is for the treatment of recalcitrant foot abscesses   knowledge of the affected area.
           (Fig. 13.17).
             The  Versajet™  hydro-surgery  system  (Smith  &  Suture materials and patterns
           Nephew, St. Petersburg, USA) (Fig. 13.18) offers a   The clinician must choose the appropriate suture
           unique way of performing precise wound debride-  material, needle and pattern. As an overall classi-
           ment. It uses a high-velocity and modifiable fluid jet   fication, there are absorbable and non-absorbable
           running parallel to the surface to draw devitalised   suture materials, which can also be mono- or mul-
           soft tissue into a cutting chamber for excision and   tifilament (Table 13.1). Ideally, the suture material
   1326   1327   1328   1329   1330   1331   1332   1333   1334   1335   1336